General Atlantic’s Blend Labs BLND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,132,440
Closed -$71.7M 17
2024
Q3
$71.7M Hold
19,132,440
2.04% 10
2024
Q2
$45.2M Hold
19,132,440
1.42% 10
2024
Q1
$62.2M Hold
19,132,440
1.44% 13
2023
Q4
$48.8M Hold
19,132,440
0.7% 15
2023
Q3
$26.2M Hold
19,132,440
0.4% 22
2023
Q2
$18.1M Hold
19,132,440
0.29% 25
2023
Q1
$19.1M Buy
19,132,440
+7,698,491
+67% +$11.8M 0.22% 24
2022
Q4
$16.5M Hold
11,433,949
0.22% 25
2022
Q3
$25.3M Hold
11,433,949
0.3% 22
2022
Q2
$27M Hold
11,433,949
0.35% 23
2022
Q1
$65.2M Hold
11,433,949
0.6% 15
2021
Q4
$83.9M Hold
11,433,949
0.65% 16
2021
Q3
$154M Buy
+11,433,949
New +$194M 0.9% 13

Other funds holding BLND

General Atlantic's BLND Position: Q4 2024 in Review

General Atlantic sold out of Blend Labs (BLND) in Q4 2024, closing a stake of 19,132,440 shares — an estimated $71.7M sold.

General Atlantic first reported a position in BLND in Q3 2021 and held it in 13 quarters. The position peaked at $154M in Q3 2021. 199 funds tracked by Wall St. Rank hold BLND as of Q4 2024.

  • General Atlantic reported no remaining Blend Labs position as of Q4 2024 after selling out during the quarter.
  • General Atlantic sold 19,132,440 Blend Labs shares in Q4 2024, an estimated $71.7M.
  • General Atlantic first reported a position in Blend Labs in Q3 2021 and held it in 13 quarters.
  • General Atlantic's Blend Labs position peaked at $154M in Q3 2021.
  • 199 funds tracked by Wall St. Rank held Blend Labs as of Q4 2024.

Based on General Atlantic's 13F filing for Q4 2024, filed 7 Feb 2025.